COMP <GO>
HR vs MS // FORWARD P/E MULTIPLE
Healthcare Realty Trust Incorporated (NYSE) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: HR 6
— MS 6
▲ FORWARD P/E MULTIPLE LEADER: MS
LAST: $18.49 (+1.99%) • MKT CAP: $6.21B
forward-pe
34.0x
LAST: $184.30 (-3.00%) • MKT CAP: $298.41B
forward-pe
16.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HR VS. MS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HR | MS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.70% | 3.00% | -6.70 | MS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 31.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.34% | -7.25% | +14.59 | HR | /fcf-yield <GO> |
| Operating Margin | -60.00% | 24.60% | -84.60 | MS | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 20.20% | -80.20 | MS | /net-margins <GO> |
| Revenue Growth (YoY) | 47.30% | 5.50% | +41.80 | HR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 6.23% | 2.21% | +4.02 | HR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.25 | 0.46 | +0.79 | HR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | HR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 7.00% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.2 | 43.3 | +16.87 | HR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 1.04 | -0.02 | MS | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 34.0x | 16.5x | +17.50 | MS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.21B | $298.41B | -$292.19B | MS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HR REV | MS REV | HR GROSS % | MS GROSS % | HR FCF | MS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $28.2M | $0 | 44.0% | — | $455.8M | -$17.89B |
| FY 2024 | $19.2M | $0 | 44.0% | — | $500.8M | $1.36B |
| FY 2023 | $17.5M | $0 | 44.0% | — | $499.0M | -$33.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HR // BETA 1.02
MS // BETA 1.04